Dang Tien Giang, Nguyen Hong Quang, Khuc Chi Hieu, Tran Trung Toan, Nguyen Thanh Long
Department of Medical Oncology No. 6, Vietnam National Cancer Hospital, Vietnam.
Department of Oncology, Hanoi Medical University, Vietnam.
Ann Med Surg (Lond). 2025 Jan 9;87(1):393-397. doi: 10.1097/MS9.0000000000002835. eCollection 2025 Jan.
Ovarian cancer with breast metastasis is an exceedingly rare entity. We hereby reported a case of ovarian cancer presenting with synchronous breast metastasis.
We report a case of a 39-year-old patient who was diagnosed with FIGO stage IV ovarian cancer, with pleural effusion and a suspected lesion in the breast. Biopsies of the breast lesion showed invasive carcinoma, immunohistochemistry stains of the breast biopsy specimen were positive for PAX-8, CA-125 markers, and negative for P53, SMA, Her2/neu, Mammaglobin. Immunohistochemistry results combined with the diagnosis of ovarian cancer helped confirm the ovarian origin of breast tumor.
Ovarian cancer presenting with breast cancer metastasis concurrently is rare. The differential diagnosis between primary breast cancer and breast metastasis from ovarian cancer is challenging and immunohistochemistry results play a crucial role in establishing a definitive diagnosis in such cases.
Oncologist and pathologist should be able to identify this rare clinical scenario promptly for early diagnosis and treatment which relies on thorough examination, imaging and immunohistochemical studies. Nevertheless, owing to the extensive spread of the disease, the prognosis for this rare clinical scenario is generally poor.
伴有乳腺转移的卵巢癌是一种极其罕见的情况。我们在此报告一例出现同步乳腺转移的卵巢癌病例。
我们报告一例39岁患者,被诊断为国际妇产科联盟(FIGO)IV期卵巢癌,伴有胸腔积液以及乳腺可疑病灶。乳腺病灶活检显示为浸润性癌,乳腺活检标本的免疫组化染色PAX - 8、CA - 125标志物呈阳性,P53、平滑肌肌动蛋白(SMA)、人表皮生长因子受体2(Her2/neu)、乳腺珠蛋白呈阴性。免疫组化结果结合卵巢癌诊断有助于证实乳腺肿瘤的卵巢起源。
同时出现乳腺癌转移的卵巢癌很罕见。原发性乳腺癌与卵巢癌乳腺转移之间的鉴别诊断具有挑战性,免疫组化结果在对此类病例做出明确诊断中起着关键作用。
肿瘤学家和病理学家应能够及时识别这种罕见的临床情况以便早期诊断和治疗,这依赖于全面检查、影像学检查和免疫组化研究。然而,由于疾病的广泛扩散,这种罕见临床情况的预后通常较差。